Anqi Zeng

1.1k total citations
45 papers, 858 citations indexed

About

Anqi Zeng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anqi Zeng has authored 45 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Anqi Zeng's work include Natural product bioactivities and synthesis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Autophagy in Disease and Therapy (4 papers). Anqi Zeng is often cited by papers focused on Natural product bioactivities and synthesis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Autophagy in Disease and Therapy (4 papers). Anqi Zeng collaborates with scholars based in China, United States and South Korea. Anqi Zeng's co-authors include Linjiang Song, Yongmei Xie, Tinghong Ye, Shaomi Zhu, Fangfang Yang, Qinxiu Zhang, Xin Liang, Li Liu, Shu Wang and Chi Liu and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Anqi Zeng

42 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anqi Zeng China 17 435 136 131 118 92 45 858
Jae In Jung South Korea 17 548 1.3× 161 1.2× 151 1.2× 61 0.5× 97 1.1× 50 1.0k
T. R. Santhosh Kumar India 19 484 1.1× 99 0.7× 135 1.0× 57 0.5× 85 0.9× 40 992
Yoo Sun Kim South Korea 17 274 0.6× 104 0.8× 140 1.1× 153 1.3× 55 0.6× 27 705
Pengtao You China 16 356 0.8× 103 0.8× 68 0.5× 102 0.9× 96 1.0× 46 823
Xuhui Tong China 9 650 1.5× 238 1.8× 139 1.1× 62 0.5× 90 1.0× 16 1.1k
Jin‐Nyoung Ho South Korea 18 482 1.1× 105 0.8× 137 1.0× 70 0.6× 96 1.0× 51 924
Raghavendra S. Patwardhan India 19 614 1.4× 78 0.6× 62 0.5× 89 0.8× 106 1.2× 35 1.0k
Yuping Liu China 20 507 1.2× 149 1.1× 149 1.1× 46 0.4× 130 1.4× 55 1.1k
Izabela Berdowska Poland 13 223 0.5× 122 0.9× 85 0.6× 87 0.7× 90 1.0× 27 706
Ayşegül Varol Germany 4 491 1.1× 162 1.2× 114 0.9× 43 0.4× 45 0.5× 7 910

Countries citing papers authored by Anqi Zeng

Since Specialization
Citations

This map shows the geographic impact of Anqi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Zeng more than expected).

Fields of papers citing papers by Anqi Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Zeng. The network helps show where Anqi Zeng may publish in the future.

Co-authorship network of co-authors of Anqi Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Anqi Zeng. A scholar is included among the top collaborators of Anqi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqi Zeng. Anqi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Zilong, et al.. (2025). Advances in Palmitoylation: A key Regulator of liver cancer development and therapeutic targets. Biochemical Pharmacology. 234. 116810–116810. 2 indexed citations
2.
Chen, Maohua, Linjiang Song, & Anqi Zeng. (2025). Harnessing nature's arsenal: Targeting the TGF-β/Smad Cascade with novel natural anti-fibrotic agents. Fitoterapia. 181. 106372–106372. 3 indexed citations
3.
Peng, Xinyi, et al.. (2024). Regulatory function of glycolysis-related lncRNAs in tumor progression: Mechanism, facts, and perspectives. Biochemical Pharmacology. 229. 116511–116511. 6 indexed citations
4.
Zeng, Anqi, Xue Chen, Ying Dai, & Junning Zhao. (2024). [Betulinic acid inhibits non-small cell lung cancer by repolarizing tumor-associated macrophages via mTOR signaling pathway].. PubMed. 49(9). 2376–2384. 1 indexed citations
5.
Liu, Li, Li Li, Ting Wang, et al.. (2024). Recent nanoengineered therapeutic advancements in sepsis management. Frontiers in Bioengineering and Biotechnology. 12. 1495277–1495277. 1 indexed citations
6.
Zhang, Peng, et al.. (2024). Terpenoids mediated cell apoptotsis in cervical cancer: Mechanisms, advances and prospects. Fitoterapia. 180. 106323–106323. 2 indexed citations
7.
Zhang, Yunchao, Jiayu Tang, Cheng Wang, et al.. (2023). Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged sword. Genes & Diseases. 11(1). 367–381. 23 indexed citations
8.
Tang, Jiayu, et al.. (2023). Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives. Current Pain and Headache Reports. 27(9). 307–319. 24 indexed citations
9.
Zeng, Anqi, et al.. (2023). The impact of SARS-COV-2 infection on menstruation. BMC Women s Health. 23(1). 5 indexed citations
10.
Zeng, Anqi, et al.. (2023). Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy. Frontiers in Immunology. 14. 1208870–1208870. 40 indexed citations
11.
Huang, Yongxiu, Anqi Zeng, & Linjiang Song. (2023). Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer. Frontiers in Immunology. 14. 1255820–1255820. 5 indexed citations
12.
Ma, Sen, Binglin Chen, Anqi Zeng, et al.. (2022). Chemical structure change of lignin extracted from bamboo biomass by maleic acid. International Journal of Biological Macromolecules. 221. 986–993. 16 indexed citations
13.
Chen, Maohua, Wei Lin, Nan Li, et al.. (2022). Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota. Frontiers in Microbiology. 13. 945533–945533. 26 indexed citations
15.
Zeng, Anqi, et al.. (2019). Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo. Bioorganic & Medicinal Chemistry. 27(12). 2546–2552. 65 indexed citations
16.
Luo, Yi, Anqi Zeng, Aiping Fang, et al.. (2019). Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma. Investigational New Drugs. 37(5). 1006–1013. 16 indexed citations
17.
Zeng, Anqi, Yan Yu, Yuqin Yao, et al.. (2017). Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models. Oncotarget. 9(3). 3794–3804. 59 indexed citations
18.
Deng, Yuanle, Yali Li, Fangfang Yang, et al.. (2017). The extract from Punica granatum (pomegranate) peel induces apoptosis and impairs metastasis in prostate cancer cells. Biomedicine & Pharmacotherapy. 93. 976–984. 90 indexed citations
19.
Yang, Fangfang, Tinghong Ye, Zhihao Liu, et al.. (2016). Niclosamide induces colorectal cancer apoptosis, impairs metastasis and reduces immunosuppressive cells in vivo. RSC Advances. 6(107). 106019–106030. 9 indexed citations
20.
Yang, Fangfang, Yang Yu, Qian Lei, et al.. (2014). Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro. Biomedicine & Pharmacotherapy. 69. 402–408. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026